The report segments the cytogenetics market based on type, technique, end-user, and geography
Portland, OR -- (SBWIRE) -- 01/05/2018 -- Molecular cytogenetics, which is the combination of molecular biology and cytogenetics finds application in the field of biology and medicine. It is used to study the structural and functional organization of chromosomes and nucleus in medicinal and cancer-related genetics.
Increase in prevalence of chronic diseases such as cancer and genetic disorders, and focus on targeted cancer treatment majorly drive the market. In addition, increase in application of cytogenetics in clinical pathological testing boosts the market growth. However, high cost of advanced treatments and unfavorable reimbursement scenario restricts the growth.
Get the sample copy of this report: https://www.alliedmarketresearch.com/request-toc-and-sample/2116
The report segments the cytogenetics market based on type, technique, end-user, and geography. On the basis of type, the market is segmented into instruments and reagents, and kits. According to the technique, it is segmented into genomic in situ hybridization (GISH), fluorescence in situ hybridization (FISH), multicolour fluorescence in situ hybridization, comparative genomic hybridization (CGH), array comparative genomic hybridization, and other molecular cytogenetic techniques. By end-user, it is divided into pharmaceutical & biotechnology companies, clinical research laboratories, research & academic institutes, hospitals, and diagnostic centers.
Make a purchase enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/2116
The major key players operating in this market include Thermo Fisher Scientific Inc., GeneDx, CytoTest Inc., Empire Genomics, Abbott Laboratories, Agilent Technologies, and PerkinElmer Inc.
Cytogenetics Market Key Segments
-Reagents & Kits
-Genomic In Situ Hybridization (GISH)
-Fluorescence In Situ Hybridization (FISH)
-Multicolour Fluorescence In Situ Hybridization
-Comparative Genomic Hybridization (CGH)
-Array Comparative Genomic Hybridization
-Other Molecular Cytogenetic Techniques
-Pharmaceutical & Biotechnology Companies
-Clinical Research Laboratories
-Research & Academic Institutes